Paul Tudor Jones Aerie Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $311,327 - $744,351	48,874 New	48,874 $739,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $417,458 - $772,508	-84,335 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $184,631 - $320,812	32,736 Added 63.44%	84,335 $767,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $125,601 - $238,500	-17,892 Reduced 25.75%	51,599 $362,000
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $786,638 - $1.16 Million	69,491 New	69,491 $792,000
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $575,913 - $720,651	-37,989 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $498,415 - $793,970	37,989 New	37,989 $679,000
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $156,659 - $216,567	-14,977 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $50,520 - $67,907	4,210 Added 39.1%	14,977 $221,000
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $127,481 - $274,773	10,767 New	10,767 $145,000
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $550,188 - $779,329	-31,049 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $263,355 - $400,540	14,305 Added 85.43%	31,049 $597,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $485,073 - $807,228	16,744 New	16,744 $495,000
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $559,858 - $716,750	-11,010 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $535,086 - $661,701	11,010	11,010 $535,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.